The state of Georgia currently has 25 active clinical trials seeking participants for Ulcerative Colitis research studies. These trials are conducted in various cities, including Atlanta, Augusta, Decatur and Savannah.
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
The present study D5272C00001 (Legacy # 3151-201-008) seeks to evaluate the efficacy and safety of brazikumab versus placebo in patients with moderately to severely active UC and will include assessments of clinical responses as demonstrated by improvement of symptoms and of colonic mucosal appearance as observed on endoscopy.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/19/2021
Locations: Research Site, Atlanta, Georgia +2 locations
Conditions: Ulcerative Colitis